Literature DB >> 1190862

Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma.

A Breslow.   

Abstract

From a retrospective study of 97 and a prospective study of 41 Stage I cutaneous melanomas, it was found that tumor thickness is a better measure of prognosis than is the level of invasion of the tumor. The chance of developing recurrent disease appears to be directly proportional to tumor thickness. Prophylactic lymph node dissection doubled the rate of survival for patients with lesions greater than 1.50 mm thick but had no effect on those with thinner lesions. Thirty-nine per cent of the patients had lesions less than 0.76 mm thick and all survived free of disease for 5 or more years. Six per cent of the tumors that recurred or metastasized were in an intermediate range of 0.76-1.50 mm thick, and no discriminant could be found to separate these 9 lesions with a bad prognosis from the remaining 18 in this group.

Entities:  

Mesh:

Year:  1975        PMID: 1190862      PMCID: PMC1344040          DOI: 10.1097/00000658-197511000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  7 in total

1.  Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck.

Authors:  M G Hansen; A B McCarten
Journal:  Am J Surg       Date:  1974-10       Impact factor: 2.565

2.  Prognostic factors in cutaneous malignant melanoma. A comparative study of long term and short term survivors.

Authors:  A G Huvos; A P Shah; V Miké
Journal:  Hum Pathol       Date:  1974-05       Impact factor: 3.466

3.  Treatment of malignant melanoma: wide excision alone vs lymphadenectomy.

Authors:  F G Conrad
Journal:  Arch Surg       Date:  1972-04

4.  Prognostic significance of lymph node dissection in the treatment of malignant melanoma.

Authors:  H S Goldsmith; J P Shah; D H Kim
Journal:  Cancer       Date:  1970-09       Impact factor: 6.860

5.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

6.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

Authors:  W H Clark; L From; E A Bernardino; M C Mihm
Journal:  Cancer Res       Date:  1969-03       Impact factor: 12.701

7.  Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage).

Authors:  H J Wanebo; J Woodruff; J G Fortner
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

  7 in total
  54 in total

1.  Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.

Authors:  R D Ramirez; S D'Atri; E Pagani; T Faraggiana; P M Lacal; R S Taylor; J W Shay
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  Cutaneous malignant melanoma.

Authors:  S T Norvell; A J Bodurtha
Journal:  Can Fam Physician       Date:  1985-06       Impact factor: 3.275

3.  Pirin inhibits cellular senescence in melanocytic cells.

Authors:  Silvia Licciulli; Chiara Luise; Gaia Scafetta; Maria Capra; Giuseppina Giardina; Paolo Nuciforo; Silvano Bosari; Giuseppe Viale; Giovanni Mazzarol; Chiara Tonelli; Luisa Lanfrancone; Myriam Alcalay
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

4.  Primary malignant melanoma of the scrotum.

Authors:  J W Moul; C K Ho; D G McLeod
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

5.  Plastic surgery: treatment of melanoma.

Authors:  S Blois; W Epstein; R Dakin; M Gromet
Journal:  West J Med       Date:  1976-08

6.  Tumor thickness as an independent risk factor of early recurrence in oral cavity squamous cell carcinoma.

Authors:  Fábio Roberto Pinto; Leandro Luongo de Matos; Filipe Cavalcanti Palermo; Marco Aurélio Vamondes Kulcsar; Beatriz Godói Cavalheiro; Evandro Sobroza de Mello; Venâncio Avancini Ferreira Alves; Cláudio Roberto Cernea; Lenine Garcia Brandão
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-27       Impact factor: 2.503

7.  A rational approach to the surgical management of melanoma.

Authors:  E C Holmes; H S Moseley; D L Morton; W Clark; D Robinson; M M Urist
Journal:  Ann Surg       Date:  1977-10       Impact factor: 12.969

8.  Malignant melanoma of the eyelid skin: histopathology and behaviour.

Authors:  A Garner; L Koornneef; A Levene; J R Collin
Journal:  Br J Ophthalmol       Date:  1985-03       Impact factor: 4.638

9.  Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.

Authors:  H J Wanebo; P H Cooper; R W Hagar
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

10.  Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma.

Authors:  R W Griffiths; J C Briggs
Journal:  Ann R Coll Surg Engl       Date:  1985-03       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.